"phase transformation initiation" trang 11 - tải miễn phí từ tailieunhanh
Protocol for the P3BEP trial (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours

Protocol for the P3BEP trial (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours
6    145    0
Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial

Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial
10    87    0
Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer

Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer
8    103    0
Effect of temperature and time of baking phase on SU-8 PR film used as a hard mask for a deep lithography

Effect of temperature and time of baking phase on SU-8 PR film used as a hard mask for a deep lithography
5    79    1
A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma

A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma
7    40    1
A web tool for designing and conducting phase I trials using the continual reassessment method

A web tool for designing and conducting phase I trials using the continual reassessment method
8    65    1
Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): An open label, non-comparative, phase II trial

Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): An open label, non-comparative, phase II trial
10    84    1
Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: A phase II study

Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: A phase II study
7    78    1
Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: A multicenter phase II study (TOSA trial) protocol

Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: A multicenter phase II study (TOSA trial) protocol
4    51    1
A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer

A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer
10    61    1
Effect of supplementation of trace minerals and vitamins during transition phase on lactation performance of deoni primiparous heifers

Effect of supplementation of trace minerals and vitamins during transition phase on lactation performance of deoni primiparous heifers
7    75    1
Study of specific energy in elastic phase of the different metallic materials: aluminium, copper and steel

Study of specific energy in elastic phase of the different metallic materials: aluminium, copper and steel
6    44    1
Source and sink activity during reproductive phase of rice (Oryza sativa L.)

Source and sink activity during reproductive phase of rice (Oryza sativa L.)
8    40    1
Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study

Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study
7    61    1
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: A multicentre, randomised controlled openlabel phase II trial

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: A multicentre, randomised controlled openlabel phase II trial
10    34    1
Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
8    42    1
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: A dose-finding phase 1 trial

Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: A dose-finding phase 1 trial
7    49    1
Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: A phase 1 dose-escalation trial

Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: A phase 1 dose-escalation trial
7    38    1
Multipartite disentanglement dynamics due simultaneously to amplitude damping and phase damping

Multipartite disentanglement dynamics due simultaneously to amplitude damping and phase damping
17    38    1
BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: A first-inhuman phase-I study

BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: A first-inhuman phase-I study
8    42    1